Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function - Implications for a strategy of salvage transplantation

被引:712
作者
Poon, RTP
Fan, ST
Lo, CM
Liu, CL
Wong, J
机构
[1] Univ Hong Kong, Queen Mary Hosp, Med Ctr, Dept Surg, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Queen Mary Hosp, Med Ctr, Ctr Study Liver Dis, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
10.1097/00000658-200203000-00009
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective To evaluate the survival results and pattern of recurrence after resection of potentially transplantable small hepatocellular carcinomas (HCC) in patients with preserved liver function, with special reference to the implications for a strategy of salvage transplantation. Summary Background Data Primary resection followed by transplantation for recurrence or deterioration of liver function has been recently suggested as a rational strategy for patients with HCC 5 cm or smaller and preserved liver function, However, there are no published data on transplantability after HCC recurrence or long-term deterioration of liver function after resection of small HCC in Child-Pugh class A patients. Such data are critical in determining the feasibility of salvage transplantation. Methods From a prospective database of 473 patients with resection of HCC between 1989 and 1999, 135 patients age 65 years or younger had Child-Pugh class A chronic liver disease (chronic hepatitis or cirrhosis) and transplantable small HCC (solitary less than or equal to5 cm or two or three tumors less than or equal to3 cm). Survival results were analyzed and the pattern of recurrence was examined for eligibility for salvage transplantation based on the same criteria as those of primary transplantation for HCC. Results Overall survival rates at 1, 3, 5, and 10 years were 90%, 76%, 70%, and 35%, respectively, and the corresponding disease-free survival rates were 74%, 50%, 36%, and 22%. Cirrhosis and oligonodular tumors were predictive of worse disease-free survival. Patients with concomitant oligonodular tumors and cirrhosis had a 5-year overall survival rate of 48% and a disease-free survival rate of 0%, which were significantly worse compared with other subgroups. At a median follow-up of 48 months, 67 patients had recurrence and 53 (79%) of them were considered eligible for salvage transplantation. Decompensation from Child-Pugh class A to B or C without recurrence occurred in only six patients. Conclusions For Child-Pugh class A patients with small HCC, hepatic resection is a reasonable first-line treatment associated with a favorable 5-year overall survival rate, A considerable proportion of patients may survive without recurrence for 5 or even 10 years; among those with recurrence, the majority may be eligible for salvage transplantation. These data suggest that primary resection and salvage transplantation may be a feasible and rational strategy for patients with small HCC and preserved liver function. Primary transplantation may be a preferable option for the subset of patients with oligonodular tumors in cirrhotic liver in view of the poor survival results after resection.
引用
收藏
页码:373 / 382
页数:10
相关论文
共 45 条
[1]   RISK-FACTORS FOR INTRAHEPATIC RECURRENCE IN HUMAN SMALL HEPATOCELLULAR-CARCINOMA [J].
ADACHI, E ;
MAEDA, T ;
MATSUMATA, T ;
SHIRABE, K ;
KINUKAWA, N ;
SUGIMACHI, K ;
TSUNEYOSHI, M .
GASTROENTEROLOGY, 1995, 108 (03) :768-775
[2]   INTRAHEPATIC RECURRENCE AFTER RESECTION OF HEPATOCELLULAR-CARCINOMA COMPLICATING CIRRHOSIS [J].
BELGHITI, J ;
PANIS, Y ;
FARGES, O ;
BENHAMOU, JP ;
FEKETE, F .
ANNALS OF SURGERY, 1991, 214 (02) :114-117
[3]   LIVER RESECTION VERSUS TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS [J].
BISMUTH, H ;
CHICHE, L ;
ADAM, R ;
CASTAING, D ;
DIAMOND, T ;
DENNISON, A .
ANNALS OF SURGERY, 1993, 218 (02) :145-151
[4]   Liver transplantation for hepatocellular carcinoma [J].
Bismuth, H ;
Majno, PE ;
Adam, R .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :311-322
[5]  
CASTELLS A, 1993, HEPATOLOGY, V18, P1121
[6]   Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation? [J].
Colella, G ;
DeCarlis, L ;
Rondinara, GF ;
Sansalone, CV ;
Belli, LS ;
Aseni, P ;
Slim, AI ;
Gelosa, F ;
Iamoni, GM ;
Corti, A ;
Mazza, E ;
Arcieri, K ;
Giacomoni, A ;
Minola, E ;
Ideo, G ;
Forti, D .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :492-494
[7]   The long-term course of chronic hepatitis B [J].
Di Marco, V ;
Lo Iacono, O ;
Cammà, C ;
Vaccaro, A ;
Giunta, M ;
Martorana, G ;
Fuschi, P ;
Almasio, PL ;
Craxì, A .
HEPATOLOGY, 1999, 30 (01) :257-264
[8]  
Dmitrewski J, 1998, J Hepatobiliary Pancreat Surg, V5, P18, DOI 10.1007/PL00009945
[9]   Rising incidence of hepatocellular carcinoma in the United States [J].
El-Serag, HB ;
Mason, AC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :745-750
[10]   Hepatectomy for hepatocellular carcinoma: Toward zero hospital deaths [J].
Fan, ST ;
Lo, CM ;
Liu, CL ;
Lam, CM ;
Yuen, WK ;
Yeung, C ;
Wong, J .
ANNALS OF SURGERY, 1999, 229 (03) :322-330